I agree that this site is using cookies. You can find further informations here.
X
Hernandez-Ilizaliturri, Francisco J
135  results:
Search for persons X
?
1

Plain language summary of the TRANSFORM study primary analy..:

Abramson, Jeremy S ; Solomon, Scott R ; Arnason, Jon...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
2

Pharmacologic targeting of Nedd8-activating enzyme reinvigo..:

Wang, Xiaoguang ; Chen, Canping ; Vuong, Dan...
Leukemia.  37 (2023)  6 - p. 1324-1335 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Carfilzomib combined with rituximab, ifosfamide, carboplati..:

Torka, Pallawi ; Groman, Adrienne ; Wong, Jerry...
Blood Advances.  7 (2023)  7 - p. 1146-1155 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Population Pharmacokinetics and Pharmacodynamics of Carfilz..:

Lin, Lan-Hsi ; Ghasemi, Mohammad ; Burke, Sarah M....
Targeted Oncology.  18 (2023)  5 - p. 685-695 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Lisocabtagene maraleucel as second-line therapy for large B..:

Abramson, Jeremy S. ; Solomon, Scott R. ; Arnason, Jon...
Blood.  141 (2023)  14 - p. 1675-1684 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Primary Analysis (PA) Results from the Randomized, Phase 3 ..:

Abramson, Jeremy S. ; Solomon, Scott R. ; Arnason, Jon...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S36-S37 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Outcomes of patients with blastoid and pleomorphic variant ..:

Gerson, James N. ; Handorf, Elizabeth ; Villa, Diego...
Blood Advances.  7 (2023)  24 - p. 7393-7401 , 2023
Link: https://doi.org/10.1182/..
 
?
8

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combi..:

Torka, Pallawi ; Kambhampati, Swetha ; Chen, Lu...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimer..:

Kamdar, Manali ; Solomon, Scott R. ; Arnason, Jon E....
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S56-S57 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Lisocabtagene maraleucel versus standard of care with salva..:

Kamdar, Manali ; Solomon, Scott R ; Arnason, Jon...
The Lancet.  399 (2022)  10343 - p. 2294-2308 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Pembrolizumab plus dinaciclib in patients with hematologic ..:

Gregory, Gareth P. ; Kumar, Shaji ; Wang, Ding...
Blood Advances.  6 (2022)  4 - p. 1232-1242 , 2022
Link: https://doi.org/10.1182/..
 
?
12

Small molecule MMRi62 targets MDM4 for degradation and indu..:

Lama, Rati ; Xu, Chao ; Galster, Samuel L....
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
13

A Dose-Response Relationship to Radiotherapy for Cutaneous ..:

Farrugia, Mark K. ; Morrison, Carl ; Hernandez-Ilizaliturri, Francisco..
Case Reports in Oncological Medicine.  2021 (2021)  - p. 1-6 , 2021
Link: https://doi.org/10.1155/..
 
?
14

Metformin sensitizes therapeutic agents and improves outcom..:

Singh, Anil R. ; Gu, Juan J. ; Zhang, Qunling...
Cancer & Metabolism.  8 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
15

The adhesion molecule ICAM-1 in diffuse large B-cell lympho..:

Liu, Yizhen ; Gu, Juan J. ; Yang, Ling...
Aging.  13 (2020)  1 - p. 181-193 , 2020
Link: https://doi.org/10.18632..
 
1-15